Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Shares of ResMed Inc. RMD slipped 2.47% to $220.22 Wednesday, on what proved to be an all-around mixed trading session for ...

Resmed, a leader in sleep technology, unveiled its latest global health consumer campaign, ‘Say goodbye to your sleep monster’ via the aptly named independent creative agency Hopeful Monsters. To help ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

ResMed showed 29% EPS growth last quarter. Sales gains came in at 10%. ResMed earns the No. 6 rank among its peers in the Medical-Products industry group. Boston Scientific, Penum ...

Resmed RMD has unveiled a comprehensive brand evolution to lead the global sleep and health technology revolution. The strategy unifies all Resmed brands under a single health technology brand, aiming ...

Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to connectivity, ...

Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...

Sleep technology company Resmed has launched a new global campaign, enlisting the help of a ‘sleep monster’ developed by local creative agency partner Hopeful Monsters.The latest consumer health ...

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

At the forefront of this revolution are players like NVIDIA, whose AI computing platforms are accelerating AI-powered medical ...

Resmed, a leader in sleep technology, has unveiled its latest global health consumer campaign, ‘Say goodbye to your sleep monster’ via the aptly named independent creative agency Hopeful Monsters.